Gesellschaftsrecht / M&A

Kapitalmarkt

Arbeitsrecht und Vergütung für Führungskräfte

Finanzierungen und Anlageprodukte

Steuern

Galderma-webnews

Homburger News

Homburger and Galderma

On March 13, 2024, Galderma Group AG (Galderma), the pure-play dermatology category leader, announced the launch of its Initial Public Offering (Offering) on the SIX Swiss Exchange. The Offering consists of up to 40,453,467 newly issued shares and up to 276,909 existing shares sold by one of its shareholders, Sunshine SwissCo AG (EQT), with an over-allotment option of up to 6,109,158 existing registered shares granted by EQT together with the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd.
Based on the offer price range between CHF 49 and CHF 53 resulting in an offer size of approximately CHF 2.3 billion (assuming the over-allotment option is exercised in full), the implied market capitalization of Galderma is estimated between CHF 11.8 billion and CHF 12.6 billion. The listing and the first day of trading are expected to take place on March 22, 2024. Galderma will be included in the Swiss Performance Index (SPI).
Homburger acts as issuer&#8217;s, selling shareholder&#8217;s and transaction counsel to Galderma and EQT. The team is led by Frank Gerhard, Lorenzo Togni and Margrit Marti (all Capital Markets; Corporate/M&amp;A) and comprises Micha Fankhauser, Estelle Piccard, Jasmin Künzle, Héloïse de Jamblinne, Lucas Forrer and Daniel Wenzinger (all Capital Markets; Corporate/M&amp;A), Andreas Müller and Anna Peter (Employment and Executive Compensation), Jürg Frick, Stefan Bindschedler, Daniel Junginger and Sarah Fasel (all Financing and Investment Products), Stefan Oesterhelt and Laetitia Fracheboud (both Tax).

Homburger advises Galderma on its IPO on SIX Swiss Exchange

Wettbewerb

Regulierung

IP / IT

Vencora_webnews

Homburger and Vencora and Constellation Software Inc.

On November 16, 2023, Vencora UK Limited, an indirect subsidiary of Volaris Group Inc. and Constellation Software Inc. (CSI), a Canadian-based international provider of software and services (TSX: CSU), and Crealogix Holding AG, a Swiss-based global leader in digital banking technology (SIX: CLXN), jointly announced that they have entered into a definitive transaction agreement, under which Vencora agreed to submit an all-cash public tender offer to acquire all publicly held registered shares of Crealogix for CHF 60 per share, for an aggregate equity value for Crealogix of approximately CHF 84 m. Vencora published its pre-announcement of the offer today. Certain shareholders of Crealogix have concurrently entered into a share purchase agreement with Vencora for the sale of a total of 51.66% of all shares in Crealogix to Vencora.
The offer and the share purchase agreement with the selling shareholders are conditional upon the receipt of regulatory clearances in certain jurisdictions and other customary conditions.
Homburger AG advises Vencora and CSI on the transaction. The Homburger team is led by Daniel Hasler (Corporate / M&amp;A) and comprises Micha Fankhauser, Carlo Sulser, Léonard Aeschlimann Perales, Oliver Kneubühl, Thierry Burckhardt, Héloïse De Jamblinne, Aron Belegu, Thomas Waidacher, Jana Waldvogel and Sabrina Vieli (all Corporate / M&amp;A), Manuel Baschung (Financing and Investment Products), Richard Stäuber and Christoph Grüninger (both Competition, Regulatory), Joel Fink (IP / IT) and Giulia Menegon (Employment and Executive Compensation).

Homburger advises Vencora UK Limited, an indirect subsidiary of Volaris Group Inc. and Constellation Software Inc., with respect to its announced public tender offer for all publicly held shares of Crealogix Holding AG

Héloïse
de Jamblinne

Homburger advises Galderma on its IPO on SIX Swiss Exchange

Homburger advises Vencora UK Limited, an indirect subsidiary of Volaris Group Inc. and Constellation Software Inc., with respect to its announced public tender offer for all publicly held shares of Crealogix Holding AG

Memorandum for Incoming Directors on their Duties and Potential Liabilities (Switzerland)

Join the Team

Héloïse de Jamblinne

Karriere

Sprachen

Zulassung

Teams

Héloïsede Jamblinne

Homburger advises Galderma on its IPO on SIX Swiss Exchange

Homburger advises Vencora UK Limited, an indirect subsidiary of Volaris Group Inc. and Constellation Software Inc., with respect to its announced public tender offer for all publicly held shares of Crealogix Holding AG

Memorandum for Incoming Directors on their Duties and Potential Liabilities (Switzerland)

Join the Team

Héloïse de Jamblinne

Karriere

Sprachen

Zulassung

Teams

Héloïse
de Jamblinne